STAAR Surgical | STAA - Selling And Administration Expenses

Stock Price
25.67
Daily Change
0.83 3.34%
Monthly
33.77%
Yearly
42.37%
Q2 Forecast
25.12

STAAR Surgical reported $38.94M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Bausch Health Companies USD 801M 6M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Cooper Companies USD 373.1M 46.1M Dec/2025
J&J USD 6.03B 719M Mar/2026
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Novartis USD 3.44B 128M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Orthofix International USD 130.35M 11.31M Dec/2025
Rockwell Medical USD 4.04M 330K Jun/2024
STAAR Surgical USD 38.94M 20.44M Dec/2025
Utah Medical Products USD 2.61M 741K Dec/2025